Mrv0541 02231219592D 16 17 0 0 1 0 999 V2000 22.4323 -19.7753 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 24.0780 -17.2027 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 22.7196 -16.7587 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.0754 -19.7753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 20.3854 -19.1079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 20.3854 -20.4428 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 22.2070 -18.3272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 23.0143 -18.1571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.9508 -19.1114 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 21.1700 -19.3628 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 21.1700 -20.1879 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 21.9508 -20.4393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 23.2707 -17.3728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.9004 -19.7753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.1709 -18.7028 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 21.1709 -20.8479 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 9 1 0 0 0 0 1 12 1 0 0 0 0 2 13 1 0 0 0 0 3 13 2 0 0 0 0 4 14 2 0 0 0 0 5 10 1 0 0 0 0 5 14 1 0 0 0 0 6 11 1 0 0 0 0 6 14 1 0 0 0 0 7 8 1 0 0 0 0 9 7 1 6 0 0 0 8 13 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 10 15 1 1 0 0 0 11 12 1 0 0 0 0 11 16 1 1 0 0 0 M END > BMDB0004821 > bmdb > [H][C@]12CS[C@@H](CCC(O)=O)[C@@]1([H])NC(=O)N2 > InChI=1S/C8H12N2O3S/c11-6(12)2-1-5-7-4(3-14-5)9-8(13)10-7/h4-5,7H,1-3H2,(H,11,12)(H2,9,10,13)/t4-,5-,7-/m0/s1 > QDFGCLSCEPNVQP-VPLCAKHXSA-N > C8H12N2O3S > 216.257 > 216.05686295 > 3 > 20.683997060338108 > 1 > 3 > 0 > 0 > 3-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]propanoic acid > -0.76 > -0.5697136819999999 > -1.83 > 0 > 2 > -1 > 13.384795303408737 > 4.2392109223524885 > -1.8636487382586329 > 78.42999999999999 > 50.8489 > 3 > 1 > 3.19e+00 g/l > 3-[(3aS,4S,6aR)-2-oxo-hexahydrothieno[3,4-d]imidazolidin-4-yl]propanoic acid > 0 > BMDB0004821 > Bisnorbiotin > hexahydro-2-oxo-1H-Thieno[3,4-d]imidazole-4-propionic acid; [3aS-(3aa,4b,6aa)]-hexahydro-2-oxo-1H-Thieno[3,4-d]imidazole-4-propanoate; [3aS-(3aa,4b,6aa)]-hexahydro-2-oxo-1H-Thieno[3,4-d]imidazole-4-propanoic acid $$$$